Your browser doesn't support javascript.
loading
Feasibility and Clinical Utility of Patient-Reported Outcome Measurement Information System-29 in a Newly Established Adolescent and Young Adult Oncology Program.
Smith, Patrick; Snyder, Benjamin; McDaniel, Maria; St Ville, Madeleine; Cull, Elizabeth; Siembida, Elizabeth J; Saha, Aniket.
Afiliación
  • Smith P; USC School of Medicine Greenville, Greenville, South Carolina, USA.
  • Snyder B; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • McDaniel M; USC School of Medicine Greenville, Greenville, South Carolina, USA.
  • St Ville M; Department of Pediatrics, Prisma Health Upstate Children's Hospital, Greenville, South Carolina, USA.
  • Cull E; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
  • Siembida EJ; USC School of Medicine Greenville, Greenville, South Carolina, USA.
  • Saha A; Prisma Health Cancer Institute, Greenville, South Carolina, USA.
Article en En | MEDLINE | ID: mdl-38959166
ABSTRACT

Purpose:

Despite improvements in survival, adolescent and young adult (AYA) oncology patients are at high risk for experiencing negative health-related quality of life (HRQOL) outcomes. AYA cancer programs have attempted to develop assessment tools to identify areas of need. We aimed to demonstrate the feasibility/utility of the Patient-Reported Outcome Measurement Information System®-29 (PROMIS®-29) within an AYA oncology program clinic.

Methods:

AYA patients were referred by oncologists to the AYA oncology program at Prisma Health. The PROMIS-29 v2.0 survey was administered to AYAs at point of care. Feasibility of distribution and completion rate of surveys were determined. PROMIS surveys were self-reported and subsequently scored using standardized methods. The domains assessed included physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles/activities, pain interference, and pain intensity. Qualitative descriptions of AYA care delivery based on survey responses at the patient level and programmatic level are also presented.

Results:

Between May 2017 and 2019, 134 AYAs who were newly diagnosed or in treatment completed the survey. Distribution and completion rates for the PROMIS-29 were both 100%, and meaningful changes in program-level services were implemented as a result of PROMIS-29 score patterns. Within the entire cohort, T-scores for anxiety, fatigue, and physical function reached clinically relevant thresholds.

Conclusion:

PROMIS offers a feasible opportunity for AYA programs to measure clinically useful HRQOL outcomes in AYAs. The survey can be used to deliver real-time AYA care to recently diagnosed and in-treatment AYAs and make programmatic changes within AYA oncology programs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Adolesc Young Adult Oncol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Adolesc Young Adult Oncol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos